Choose the experimental features you want to try

This document is an excerpt from the EUR-Lex website

Document 52003XC1128(02)

    Summary of Community decisions on marketing authorisations in respect of medicinal products from 15 October 2003 to 15 November 2003 (Decisions taken pursuant to Article 34 of Directive 2001/83/EC or Article 38 of Directive 2001/82/EC)

    OJ C 285, 28.11.2003, p. 6–12 (ES, DA, DE, EL, EN, FR, IT, NL, PT, FI, SV)

    52003XC1128(02)

    Summary of Community decisions on marketing authorisations in respect of medicinal products from 15 October 2003 to 15 November 2003 (Decisions taken pursuant to Article 34 of Directive 2001/83/EC or Article 38 of Directive 2001/82/EC)

    Official Journal C 285 , 28/11/2003 P. 0006 - 0012


    Summary of Community decisions on marketing authorisations in respect of medicinal products from 15 October 2003 to 15 November 2003

    (Decisions taken pursuant to Article 34 of Directive 2001/83/EC(1) or Article 38 of Directive 2001/82/EC(2))

    (2003/C 285/03)

    - Issuing, maintenance or modification of a national marketing authorisation

    >TABLE>

    (1) OJ L 311, 28.11.2001, p. 67.

    (2) OJ L 311, 28.11.2001, p. 1.

    ANNEX I

    LIST OF THE NAMES, PHARMACEUTICAL FORM, STRENGTHS OF THE MEDICINAL PRODUCTS, ROUTE OF ADMINISTRATION, APPLICANT, MARKETING AUTHORISATION HOLDER, PACKAGING AND PACKAGE SIZES IN THE MEMBER STATES

    >TABLE>

    ANNEX II

    LIST OF THE NAMES, PHARMACEUTICAL FORMS, STRENGTHS OF THE MEDICINAL PRODUCTS, ROUTE OF ADMINISTRATION, MARKETING AUTHORISATION HOLDERS, PACKAGING AND PACKAGE SIZES IN THE MEMBER STATES

    >TABLE>

    Top